Advisor Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.97M Buy
67,962
+3,588
+6% +$99.3K 0.01% 820
2019
Q3
$1.67M Sell
64,374
-1,938
-3% -$49K 0.01% 841
2019
Q2
$1.69M Sell
66,312
-10,950
-14% -$271K 0.01% 830
2019
Q1
$2.02M Sell
77,262
-34,016
-31% -$836K 0.02% 715
2018
Q4
$2.56M Buy
111,278
+16,994
+18% +$378K 0.03% 538
2018
Q3
$2.22M Buy
94,284
+19,208
+26% +$469K 0.02% 602
2018
Q2
$1.73M Sell
75,076
-7,638
-9% -$182K 0.02% 602
2018
Q1
$2.04M Sell
82,714
-46,806
-36% -$1.23M 0.03% 556
2017
Q4
$3.48M Buy
129,520
+914
+0.7% +$23.2K 0.05% 358
2017
Q3
$3.1M Sell
128,606
-940
-0.7% -$21.2K 0.05% 356
2017
Q2
$2.78M Sell
129,546
-5,272
-4% -$106K 0.05% 372
2017
Q1
$2.31M Sell
134,818
-13,988
-9% -$244K 0.05% 407
2016
Q4
$2.67M Sell
148,806
-47,468
-24% -$861K 0.06% 339
2016
Q3
$4.08M Sell
196,274
-1,196
-0.6% -$29.7K 0.1% 225
2016
Q2
$5.31M Buy
+197,470
New +$5.42M 0.14% 165

Other funds holding NVO